News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,051 Results
Type
Article (552)
Company Profile (1)
Press Release (12498)
Section
Business (3401)
Career Advice (1)
Deals (826)
Drug Development (1147)
Employer Resources (1)
FDA (245)
Job Trends (118)
News (5747)
Policy (498)
Tag
Academia (18)
Alliances (1591)
ALS (1)
Alzheimer's disease (8)
Antibody-drug conjugate (ADC) (2)
Approvals (252)
Artificial intelligence (4)
Autoimmune disease (2)
Best Places to Work (90)
Biosimilars (7)
Bladder cancer (2)
Breast cancer (10)
Cancer (48)
Cardiovascular disease (2)
Career advice (1)
CAR-T (1)
Cell therapy (8)
Clinical research (1024)
Collaboration (38)
Compensation (10)
COVID-19 (37)
CRISPR (1)
C-suite (12)
Cystic fibrosis (1)
Data (70)
Depression (1)
Diabetes (3)
Diagnostics (128)
Drug discovery (2)
Drug shortages (1)
Earnings (872)
Employer resources (1)
Events (1129)
Executive appointments (8)
FDA (285)
Funding (18)
Gene editing (2)
Gene therapy (6)
GLP-1 (10)
Government (27)
Guidances (5)
Healthcare (305)
IgA nephropathy (1)
Immunology and inflammation (3)
Indications (2)
Infectious disease (37)
Intellectual property (5)
Interviews (1)
IPO (205)
Job creations (31)
Job search strategy (1)
Layoffs (1)
Legal (148)
Liver cancer (1)
Lung cancer (4)
Lymphoma (1)
Management (1)
Manufacturing (14)
Medical device (183)
Medtech (184)
Mergers & acquisitions (639)
Metabolic disorders (4)
Multiple sclerosis (4)
Neuropsychiatric disorders (1)
Neuroscience (18)
NextGen: Class of 2026 (42)
Non-profit (4)
Obesity (1)
Pain (8)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (5)
Patient recruitment (8)
People (809)
Pharmaceutical (1)
Phase 1 (316)
Phase 2 (443)
Phase 3 (358)
Pipeline (60)
Postmarket research (41)
Preclinical (108)
Prostate cancer (3)
Radiopharmaceuticals (6)
Rare diseases (8)
Real estate (127)
Regulatory (379)
Reports (1)
Research institute (23)
Series A (6)
Service/supplier (1)
Startups (85)
Supply chain (1)
Vaccines (4)
Date
Last 7 days (3)
Last 30 days (27)
Last 365 days (338)
2026 (31)
2025 (334)
2024 (448)
2023 (554)
2022 (1825)
2021 (1627)
2020 (1116)
2019 (746)
2018 (477)
2017 (639)
2016 (518)
2015 (745)
2014 (579)
2013 (492)
2012 (564)
2011 (503)
2010 (429)
Location
Africa (6)
Arizona (1)
Asia (597)
Australia (174)
California (58)
Canada (34)
China (3)
Delaware (6)
Europe (5348)
Florida (8)
Georgia (2)
Idaho (1)
Illinois (15)
Indiana (1)
Japan (15)
Maryland (6)
Massachusetts (66)
Michigan (9)
New Jersey (27)
New York (9)
North Carolina (9)
Northern California (43)
Pennsylvania (78)
South America (17)
Southern California (7)
Texas (4)
United States (305)
Utah (7)
Washington State (1)
Wisconsin (1)
13,051 Results for "sphingotec gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Advancing Kidney Care With Solidified Evidence - SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza
Diagnostics company SphingoTec GmbH introduced together with Boditech Med Inc. at the 42nd AKI & CRRT Course in Vicenza the innovative kidney function biomarker penKid developed by SphingoTec and licensed to Boditech.
June 18, 2024
·
4 min read
Press Releases
Boditech Med and SphingoTec Announce Launch of AFIAS penKid(R) Assay for Kidney Function Diagnostics
May 6, 2025
·
5 min read
Business
SphingoTec Announces Management Changes
Diagnostic company SphingoTec announces a significant change in its management team. Joerg Menten, Managing Director and CEO, leaves the company to enter into retirement.
March 26, 2024
·
4 min read
Business
Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
Boditech Med Inc. and SphingoTec GmbH announced they have entered into a market development agreement, building on their previous licensing collaboration for the kidney function biomarker penKid.
August 31, 2023
·
4 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Press Releases
Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care
October 9, 2024
·
4 min read
Press Releases
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
November 5, 2025
·
3 min read
Press Releases
SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers
August 8, 2024
·
4 min read
Business
SphingoTec Appoints Dr. Florian Uhle as Medical Director
Diagnostic company SphingoTec is pleased to announce the appointment of Dr. Florian Uhle as the company’s new Medical Director.
February 23, 2023
·
2 min read
1 of 1,306
Next
